[1]
L. Lobo, N. Kishore, and M. Sharma, “Tenapanor-A Novel Approach for Management of Hyperphosphatemia in End Stage Renal Disease: A Clinical Study Aggregate Review: CLINICAL STUDY AGGREGATE REPORT”, J. Drug Delivery Ther., vol. 14, no. 1, pp. 176–181, Jan. 2024, doi: 10.22270/jddt.v14i1.6336.